Dalian BIO-CHEM Company Limited
603360.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥17,108 | CN¥11,271 | CN¥10,865 | CN¥8,019 |
| - Cash | CN¥652 | CN¥541 | CN¥845 | CN¥668 |
| + Debt | CN¥1,120 | CN¥889 | CN¥999 | CN¥533 |
| Enterprise Value | CN¥17,577 | CN¥11,619 | CN¥11,019 | CN¥7,884 |
| Revenue | CN¥307 | CN¥300 | CN¥448 | CN¥416 |
| % Growth | 2.3% | -33% | 7.8% | – |
| Gross Profit | CN¥107 | CN¥105 | CN¥141 | CN¥160 |
| % Margin | 34.7% | 34.9% | 31.5% | 38.5% |
| EBITDA | CN¥46 | CN¥72 | CN¥90 | CN¥138 |
| % Margin | 15.1% | 23.9% | 20.1% | 33.2% |
| Net Income | CN¥33 | CN¥42 | CN¥50 | CN¥91 |
| % Margin | 10.8% | 13.9% | 11.2% | 21.9% |
| EPS Diluted | 0.047 | 0.083 | 0.1 | 0.18 |
| % Growth | -42.9% | -17% | -44.4% | – |
| Operating Cash Flow | CN¥201 | CN¥54 | -CN¥60 | CN¥0 |
| Capital Expenditures | -CN¥11 | -CN¥3 | -CN¥19 | -CN¥26 |
| Free Cash Flow | CN¥191 | CN¥51 | -CN¥79 | -CN¥99 |